What is the role of serology for the study of chronic hepatitis b virus infection in the age of molecular biology?

Journal of Medical Virology

Volumn 80, Issue 6, 2008, Pages 974-979

  Galli, Claudio ^a   Orlandini, Elisa ^b   Penzo, Luigi ^b   Badiale, Renzo ^b   Caltran, Giacomo ^c   Valverde, Sara ^b   Gessoni, Gianluca ^b  

^a ABBOTT DIAGNOSTICS   (Italy)

^b Hospital of Chioggia   (Italy)

^c Medical Systems   (Italy)

Author keywords

Chronic hepatitis; HBV DNA; IgM anti HBc; Monitoring; Quantitative HBsAg

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M; LAMIVUDINE; VIRUS DNA;

ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; MOLECULAR BIOLOGY; SEROLOGY;

ANTI-HIV AGENTS; BIOLOGICAL MARKERS; DNA, VIRAL; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LAMIVUDINE; MOLECULAR BIOLOGY; SEROLOGIC TESTS; SEROLOGY;

HEPATITIS B VIRUS;

EID: 43249096323     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21179     Document Type: Article

References (25)

1. Almeida RPA, Cardoso DDDP. 2006. Detection of HBV-DNA by nested PCR in HBsAg and anti-HBc negative blood bank donor. J Clin Virol 36:231-234.
2. Brunetto M, Torrani Cerenzia M, Olivieri F, Piantino P, Randone A, Calvo P, Manzini P, Rocca G, Galli C, Bonino F. 1993. Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi quantitative assay for IgM anti-HBc. J Hepatol 119:431-436.
3. Centers for Disease Controls and Prevention (CDC). 1993. Sensitivity of the test for antibody to hepatitis B surface antigens. Mor Mortal Wkly Rep 42:393-408.
4. Cervantes C, Hovanec-Burns D, Gonzales R, El Shami A. 2000. Evaluation of the Immulite 2000 anti-HBc IgM assay using commercially available performance panels. Clin Chem 46:A55.
5. Chen C-H, Lee C-M, Wang J-H, Tung H-D, Hung C-H, Lu S-N. 2004. Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers. Eur J Gastroenterol Hepatol 16:1213-1218.
6. Chulanov VP, Shipulin GA, Schaefer S, Gerlich WH. 2003. Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses. J Med Virol 69:313-323.
7. Deguchi M, Yamashita N, Kagita M, Asari S, Iwatani Y, Tsuchida T, Iinuma K, Mushahwar IK. 2004. Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. J Virol Methods 115:217-222.
8. EASL International Consensus Conference on Hepatitis B. 2003. J Hepatol 39:3-25.
9. Gerlich WH, Uy A, Lambrecht F, Thomssen R. 1986. Cutoff levels of immunoglobulin IgM antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections. J Clin Microbiol 24:288-293.
10. Gerlich WH, Wend U, Glebe D. 2004. Quantitative assay of hepatitis B surface antigen in serum or plasma using Laurell electrophoresis. In: Lau J, Hamatake R, editors. Hepatitis B virus protocols book. Totowa, NJ: Humana press. pp 57-63.
11. Hatzakis A, Magiorkinis E, Haida C. 2006. HBV virological assessment. J Hepatol 44:S71-S76.
12. Hsia CC, Purcell RH, Farsid M, Lanchenbruch A, Yu MW. 2006. Quantification of hepatitis B virus genomes and infectivity in human serum samples. Transfusion 46:1829-1835.
13. Kobayashi M, Suzuki F, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kobayashi M, Suzuki Y, Arase Y, Ikeda K, Watahiki S, Iwasaki S, Miyakawa Y, Kumada H. 2007. Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with Lamivudine. J Med Virol 79:1472-1477.
14. Kohmoto M, Enomoto M, Tamori A, Habu D, Takeda T, Kawada N, Sakaguchi H, Seki S, Shiomi S, Nishiguchi S. 2005. Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment. J Med Virol 75:235-239.
15. Kuhns M, Busch M. 2006. New strategies for blood donor screening for hepatitis B virus. Mol Diagn Ther 10:77-91.
16. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP. 2004. Lack of correlation between HBsAg and HBV-DNA levels in blood donors who test positive for HBsAg and anti-HBc: Implications for future HBV screening policy. Transfusion 44: 1332-1339.
17. Lai CL, Ratziu V, Yuen M-F, Poynard T. 2003. Viral hepatitis B. Lancet 362:2089-2094.
18. Laras A, Koskinas J, Avgidis K, Hadziyannis S. 1998. Incidence and clinical significance of hepatitis B precore gene translation initiation mutations in e antigen negative patients. J Viral Hepat 5:241-248.
19. Pawlotsky J. 2003. Hepatitis B virus (HBV) DNA assay (methods and practical use) and viral kinetics. J Hepatol 39:S31-S35.
20. Rodella A, Galli C, Terlenghi L, Perandin F, Bonfanti C, Manca N. 2006. Quantitative analysis of HBsAg, IgM anti-HBc, and anti-HBc avidity in acute and chronic hepatitis B. J Clin Virol 37:206-212.
21. Rosenau J, Kreutz T, Kujawa M, Bahr MJ, Rifai K, Hooman N, Finger A, Michel G, Nashan B, Kuse E, Klempnauer J, Tillman HL, Manns MP. 2007. HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration. J Hepatol 46:635-644.
22. Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A. 2001. An international collaborative study to establish a WHO international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 80:63-71.
23. Thomas HIJ. 1997. Relative functional affinity of specific anti-core IgG in different categories of hepatitis B virus infection. J Med Virol 51:189-197.
24. Wursthorn K, Lutgehetmann M, Dandri M, Volz T, Buggisch P, Zollner B, Longerich T, Schirmacher P, Metzler F, Zankel M, Fischer C, Currie G, Brosgart C, Petersen J. 2006. Peginterferon alpha-2b plus adefovir induce cccDNA decline and HBsAg reduction in chronic hepatitis B. Hepatology 44:675-684.
25. Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma K, Miyakawa K, Tachibana K, Mizoguchi H, The Japanese Red Cross NAT Screening Research Group. 2007. Lengths of hepatitis B viremia and antigenemia in blood donors: Preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Transfusion 47:1161-1171.